Inventor
C. Anne Higley
Inventor
Newark, DE, US
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds56%
A61KPreparations for medical, dental or toiletry purposes22%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations11%
C07KPeptides11%
PatentTitleYear
6,844,318'Peptidase-cleavable, targeted antineoplastic drugs and their therapeutic use'20055,478,830'Fused-ring heterocycles for the treatment of atherosclerosis'19955,318,984'Imidazoles for the treatment of atherosclerosis'19945,310,748'Imidazoles for the treatment of atherosclerosis'19945,290,801'Benzimidazoles for the treatment of atherosclerosis'19945,166,214'Use of imidazoles for the treatment of atherosclerosis'1992Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1992–1995Patents assigned to DU PONT MERCK PHARMA (5)· patent assignee history
1992–2005Based in Newark, DE, US· patent location history
2005Patents assigned to BRISTOL MYERS SQUIBB PHARMA CO (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| DU PONT MERCK PHARMA | 5 | 1992–1995 |
| BRISTOL MYERS SQUIBB PHARMA CO | 1 | 2005 |
Locations
| Location | Patents | Span |
|---|---|---|
| Newark, Delaware, US | 6 | 1992–2005 |